Stockholders' Equity Attributable to Parent in USD of Nascent Biotech Inc. from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Nascent Biotech Inc. quarterly Stockholders' Equity Attributable to Parent history and change rate from Q1 2014 to Q2 2024.
  • Nascent Biotech Inc. Stockholders' Equity Attributable to Parent for the quarter ending 30 Jun 2024 was $-514,540, a 53.9% increase year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

Nascent Biotech Inc. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $-514,540 +$600,494 +54% 30 Jun 2024 10-Q 14 Aug 2024 2025 Q1
Q1 2024 $-256,674 +$1,039,463 +80% 31 Mar 2024 10-Q 14 Aug 2024 2025 Q1
Q4 2023 $30,367 +$1,394,441 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 $-6,410 +$1,181,530 +99% 30 Sep 2023 10-Q 14 Feb 2024 2024 Q3
Q2 2023 $-1,115,034 +$321,758 +22% 30 Jun 2023 10-Q 14 Aug 2024 2025 Q1
Q1 2023 $-1,296,137 -$624,661 -93% 31 Mar 2023 10-Q 14 Aug 2024 2025 Q1
Q4 2022 $-1,364,074 -$916,084 -204% 31 Dec 2022 10-Q 14 Feb 2024 2024 Q3
Q3 2022 $-1,187,940 -$142,627 -14% 30 Sep 2022 10-Q 14 Feb 2024 2024 Q3
Q2 2022 $-1,436,792 -$602,509 -72% 30 Jun 2022 10-Q 14 Feb 2024 2024 Q3
Q1 2022 $-671,476 -$198,971 -42% 31 Mar 2022 10-K 01 Jul 2024 2024 FY
Q4 2021 $-447,990 +$783,934 +64% 31 Dec 2021 10-Q 14 Feb 2023 2023 Q3
Q3 2021 $-1,045,313 -$234,301 -29% 30 Sep 2021 10-Q 14 Feb 2023 2023 Q3
Q2 2021 $-834,283 +$563,154 +40% 30 Jun 2021 10-Q 14 Feb 2023 2023 Q3
Q1 2021 $-472,505 +$2,403,199 +84% 31 Mar 2021 10-K/A 03 Jul 2023 2023 FY
Q4 2020 $-1,231,924 -$279,415 -29% 31 Dec 2020 10-Q 14 Feb 2022 2022 Q3
Q3 2020 $-811,012 -$9,866 -1.2% 30 Sep 2020 10-Q 14 Feb 2022 2022 Q3
Q2 2020 $-1,397,437 -$776,877 -125% 30 Jun 2020 10-Q 14 Feb 2022 2022 Q3
Q1 2020 $-2,875,704 -$2,393,540 -496% 31 Mar 2020 10-K 15 Jun 2022 2022 FY
Q4 2019 $-952,509 -$461,255 -94% 31 Dec 2019 10-Q 09 Feb 2021 2021 Q3
Q3 2019 $-801,146 -$410,511 -105% 30 Sep 2019 10-Q 09 Feb 2021 2021 Q3
Q2 2019 $-620,560 -$288,492 -87% 30 Jun 2019 10-Q 09 Feb 2021 2021 Q3
Q1 2019 $-482,164 -$395,785 -458% 31 Mar 2019 10-K 08 Jul 2021 2021 FY
Q4 2018 $-491,254 -$1,137,923 -176% 31 Dec 2018 10-Q 11 Feb 2020 2020 Q3
Q3 2018 $-390,635 -$1,561,007 -133% 30 Sep 2018 10-Q 11 Feb 2020 2020 Q3
Q2 2018 $-332,068 -$1,036,258 -147% 30 Jun 2018 10-Q 18 Nov 2019 2020 Q2
Q1 2018 $-86,379 -$820,140 -112% 31 Mar 2018 10-K 22 Jun 2020 2020 FY
Q4 2017 $646,669 -$39,006 -5.7% 31 Dec 2017 10-Q 31 Jan 2018 2018 Q3
Q3 2017 $1,170,372 -$40,962 -3.4% 30 Sep 2017 10-Q 03 Nov 2017 2018 Q2
Q2 2017 $704,190 +$1,479,408 30 Jun 2017 10-Q 09 Aug 2017 2018 Q1
Q1 2017 $733,761 +$2,302,540 31 Mar 2017 10-K 12 Jul 2019 2019 FY
Q4 2016 $685,675 +$1,537,893 31 Dec 2016 10-Q 09 Feb 2017 2017 Q3
Q3 2016 $1,211,334 +$1,915,686 30 Sep 2016 10-Q 09 Nov 2016 2017 Q2
Q2 2016 $-775,218 +$1,672,760 +68% 30 Jun 2016 10-Q 09 Aug 2016 2017 Q1
Q1 2016 $-1,568,779 +$638,210 +29% 31 Mar 2016 10-K 29 Jun 2017 2017 FY
Q4 2015 $-852,218 +$792,476 +48% 31 Dec 2015 10-Q 19 Feb 2016 2016 Q3
Q3 2015 $-704,352 30 Sep 2015 10-Q 05 Nov 2015 2016 Q2
Q2 2015 $-2,447,978 30 Jun 2015 10-Q 30 Jul 2015 2016 Q1
Q1 2015 $-2,206,989 -$756,811 -52% 31 Mar 2015 10-K 14 Jul 2016 2016 FY
Q4 2014 $-1,644,694 31 Dec 2014 10-Q 13 Feb 2015 2015 Q3
Q1 2014 $-1,450,178 31 Mar 2014 10-K 02 Jul 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.